BRD2 and adenoma: A somatotrophic pituitary adenoma was confirmed in patient 5, patient 6 presented adenoma with negative immunoreactivity to all pituitary hormones and patient 7 had an adenoma with immunoreactivity to FSH with a 10–20% cell proliferation index and was p53 negative.